Total Payments
$87,573
2023 Payments
$27,133
Companies
11
Transactions
127
Medicare Patients
1,091
Medicare Billing
$127,558
Payment Breakdown by Category
Other$43,115 (49.2%)
Consulting$23,075 (26.3%)
Travel$18,067 (20.6%)
Food & Beverage$3,180 (3.6%)
Education$136.44 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,900 | 31 | 47.8% |
| Consulting Fee | $23,075 | 15 | 26.3% |
| Travel and Lodging | $18,067 | 39 | 20.6% |
| Food and Beverage | $3,180 | 37 | 3.6% |
| Honoraria | $1,215 | 1 | 1.4% |
| Education | $136.44 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $72,263 | 98 | $0 (2023) |
| Daiichi Sankyo Inc. | $7,640 | 9 | $0 (2023) |
| Mirati Therapeutics, Inc. | $5,770 | 9 | $0 (2023) |
| PFIZER INC. | $1,223 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $223.92 | 2 | $0 (2023) |
| Genentech USA, Inc. | $132.90 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $99.00 | 1 | $0 (2023) |
| Seagen Inc. | $80.64 | 1 | $0 (2022) |
| Foundation Medicine, Inc. | $79.27 | 1 | $0 (2022) |
| Genmab U.S., Inc. | $32.01 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $27,133 | 45 | AstraZeneca Pharmaceuticals LP ($13,507) |
| 2022 | $23,514 | 34 | AstraZeneca Pharmaceuticals LP ($23,191) |
| 2021 | $36,926 | 48 | AstraZeneca Pharmaceuticals LP ($35,565) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Oncology | ||||||
| 12/12/2023 | Daiichi Sankyo Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| 12/08/2023 | Daiichi Sankyo Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| 12/07/2023 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $1,755.17 | General |
| 12/07/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $190.36 | General |
| 12/06/2023 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $946.18 | General |
| 12/06/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $249.98 | General |
| 12/06/2023 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $247.25 | General |
| 12/06/2023 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $220.98 | General |
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: Oncology | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Oncology | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Oncology | ||||||
| 10/24/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $115.61 | General |
| 08/17/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $349.30 | General |
| Category: Oncology | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $313.26 | General |
| Category: Oncology | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $125.98 | General |
| Category: Oncology | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $117.93 | General |
| Category: Oncology | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Oncology | ||||||
| 07/24/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 07/22/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Travel and Lodging | Cash or cash equivalent | $398.90 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Travel and Lodging | Cash or cash equivalent | $292.67 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 236 | 466 | $143,501 | $34,993 |
| 2022 | 3 | 246 | 429 | $96,614 | $29,547 |
| 2021 | 3 | 285 | 511 | $103,720 | $33,356 |
| 2020 | 5 | 324 | 503 | $132,938 | $29,662 |
Total Patients
1,091
Total Services
1,909
Medicare Billing
$127,558
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 137 | 337 | $102,267 | $24,270 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 55 | 70 | $28,181 | $7,543 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 29 | 40 | $7,405 | $1,850 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 19 | $5,648 | $1,329 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 104 | 216 | $51,462 | $15,078 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 51 | 63 | $20,277 | $7,121 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 64 | 121 | $19,164 | $5,738 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $3,336 | $842.00 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 15 | $2,376 | $768.91 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 91 | 191 | $45,506 | $14,793 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 117 | 236 | $38,012 | $11,940 | 31.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 32 | 34 | $11,087 | $3,756 | 33.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 37 | $6,019 | $1,840 | 30.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $3,097 | $1,028 | 33.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 118 | 245 | $68,154 | $14,062 | 20.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 66 | 89 | $33,695 | $7,562 | 22.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 39 | $11,388 | $2,338 | 20.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 44 | 55 | $9,781 | $2,083 | 21.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 25 | 30 | $3,930 | $1,842 | 46.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 20 | 23 | $2,070 | $906.79 | 43.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 22 | $3,920 | $868.12 | 22.1% |
About Rasheda Persinger, NP
Rasheda Persinger, NP is a Gerontology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1871922997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rasheda Persinger, NP has received a total of $87,573 in payments from pharmaceutical and medical device companies, with $27,133 received in 2023. These payments were reported across 127 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,900).
As a Medicare-enrolled provider, Persinger has provided services to 1,091 Medicare beneficiaries, totaling 1,909 services with total Medicare billing of $127,558. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Other Specialties Nurse Practitioner
- Location Washington, DC
- Active Since 11/08/2013
- Last Updated 04/16/2025
- Taxonomy Code 363LG0600X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871922997
Products in Payments
- TAGRISSO (Drug) $36,640
- IMFINZI (Biological) $30,397
- KRAZATI (Drug) $5,770
- LORBRENA (Drug) $1,223
- ENHERTU (Biological) $1,000
- RYBREVANT (Drug) $99.00
- TIVDAK (Biological) $80.64
- FOUNDATIONONE (Device) $79.27
- Epkinly (Drug) $32.01
- ENHERTU (Drug) $30.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gerontology Doctors in Washington
Janie Earle, Dnp, DNP
Gerontology — Payments: $7,949
Gerontology $7,949
Payal Kadakia, Np, NP
Gerontology — Payments: $5,748
Gerontology $5,748
Odette Ntam, Np, NP
Gerontology — Payments: $4,738
Gerontology $4,738
Joanne Samuels, Np, NP
Gerontology — Payments: $1,414
Gerontology $1,414
Soukeye Niang
Gerontology — Payments: $1,195
Gerontology $1,195
Lori Repp, Gnp, GNP
Gerontology — Payments: $1,192
Gerontology $1,192